Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
AMBN
REST API REST API
Homo sapiens
AMBN is differentially expressed in 118 experiments: 77 organism parts: blood, bone marrow, ... (75 more);, 84 disease states: normal, Huntington's disease, ... (82 more);, 37 cell types 71 cell lines 11 compound treatments and 52 other conditions.
Orthologs AMBN_BOVIN (Bos taurus)   Ambn (Mus musculus)   Ambn (Rattus norvegicus)   ambn (Xenopus laevis)   AMBN (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cell proliferation, proteinaceous extracellular matrix, growth factor activity, extracellular region, cell adhesion, bone mineralization, structural constituent of tooth enamel, odontogenesis of dentine-containing tooth
InterPro Term Amelin
UniProt Accession Q9NP70, Q546D7, F5H220
Search EB-eye ENSG00000178522
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-15765, E-AFMX-5, E-MTAB-24, E-MTAB-25, E-TABM-130, ... (16 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-1309, E-GEOD-19639, E-GEOD-22639, E-GEOD-2450, E-GEOD-24147, ... (15 experiments)

Factor Value U/D Experiments
GM00719
1
E-TABM-321
NC37
1
E-MTAB-37
COLO320DM
1
E-MTAB-37
COLO668
1
E-MTAB-37
SKNEP1
1
E-MTAB-37
lncap cells, DHT-treated
1
E-MTAB-62
65 more value(s).


Cell type

studied in E-GEOD-10797, E-GEOD-18811, E-AFMX-5, E-GEOD-20193, E-MTAB-24, ... (19 experiments)

Factor Value U/D Experiments
Leukocytes
1
E-GEOD-21909
erythropoietic
1
E-GEOD-9894
BDCA4+ dentritic cells
1
E-AFMX-5
memory B cell
1
E-MEXP-2360
CD34 positive
1
E-GEOD-12662
M1 macrophage
1
E-GEOD-5099
31 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-19743, E-GEOD-15960, E-MEXP-2069, E-GEOD-5550, ... (20 experiments)

Factor Value U/D Experiments
Huntington's disease
2
2
E-AFMX-6, E-GEOD-3790
cardiomyopathy
1
E-MTAB-62
cancerous
1
E-TABM-15
monoclonal gammopathy of uncertain significance
1
E-MTAB-372
malaria
1
E-MTAB-62
malaria (treated malaria)
1
E-MTAB-62
78 more value(s).


Compound treatment

studied in E-MEXP-1269, E-GEOD-5258, E-GEOD-3284, E-GEOD-5099, E-GEOD-7307, ... (8 experiments)

Factor Value U/D Experiments
Cxcl12
1
E-GEOD-7307
no estradiol
1
E-GEOD-20081
interferon-gamma + lipopolysaccharide
1
E-GEOD-5099
bacterial endotoxin
1
1
E-GEOD-3284
control
1
1
24
E-GEOD-3284, E-GEOD-5339
colchicine
1
E-GEOD-5258
5 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


Biopsy tissue
studied in E-GEOD-5851

Biosource provider
studied in E-GEOD-20559

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, E-GEOD-16363 ... (5 experiments)

Clinical info
studied in E-GEOD-19743, E-GEOD-21589, E-GEOD-16363, E-GEOD-18995

Clinical treatment
studied in E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140, E-GEOD-2666, E-MTAB-62

Disease staging
studied in E-GEOD-19743, E-GEOD-22541, E-GEOD-22148, E-GEOD-21138

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-7578

Genotype
studied in E-GEOD-17476, E-GEOD-22593, E-TABM-321

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-GEOD-21653, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-MEXP-2069, E-GEOD-19330, E-TABM-666, E-GEOD-19519, E-GEOD-16363, ... (14 experiments)

Infection
studied in E-GEOD-12108

Injury
studied in E-GEOD-19743

Ki67 ihc
studied in E-GEOD-21653

Labeling
studied in E-LGCL-5

Material type
studied in E-MEXP-455

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Organism
studied in E-GEOD-1801, E-TABM-84

Performer
studied in E-GEOD-2004, E-LGCL-5

Phenotype
studied in E-GEOD-1309

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-21837, E-GEOD-19445, E-GEOD-19246, E-GEOD-1343

RNAi
studied in E-GEOD-3697, E-MEXP-1857, E-MEXP-2759

Sample preparation
studied in E-GEOD-16728

Sampling time point
studied in E-GEOD-19743

Sirna
studied in E-GEOD-21575

Survival time
studied in E-GEOD-3494, E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Treatment
studied in E-GEOD-16837

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Vehicle
studied in E-GEOD-5258

Processing time: 0.56 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM